Département d'anesthésie et de Réanimation, Institut Paoli-Calmettes, Marseille, France.
Département de Chirurgie, Institut Paoli Calmette, Marseille, France.
Ann Surg Oncol. 2023 Dec;30(13):8083-8093. doi: 10.1245/s10434-023-14365-8. Epub 2023 Oct 9.
The number of elderly patients undergoing major abdominal surgery is increasing, but the factors affecting their postoperative outcomes remain unclear. This study aimed to identify the factors associated with 1-year mortality among elderly patients (age ≥ 80 years) with cancer undergoing major abdominal surgery.
This retrospective cohort study was conducted from March 2009 to December 2020. The study enrolled 378 patients 80 years old or older who underwent major abdominal surgery. The main outcome was 1-year mortality, and the factors associated with mortality were analyzed.
Of the 378 patients, 92 died at 1 year (24.3%), whereas the 30-day mortality rate was 4% (n = 15). In the multivariate analysis, the factors independently associated with 1-year mortality were preoperative Eastern Cooperative Oncology Group (ECOG) performance status (PS) score higher than 1 (odds ratio [OR], 3.189; 95% confidence interval [CI], 1.595-6.377; p = 0.001), preoperative weight loss greater than 3 kg (OR, 2.145; 95% CI, 1.044-4.404; p = 0.038), use of an intraoperative vasopressor (OR, 3.090; 95% CI, 1.188-8.042; p = 0.021), and postoperative red blood cell units (OR, 1.212; 95% CI, 1.045-1.405; p = 0.011). Survival was associated with perioperative management according to an enhanced recovery after surgery (ERAS) protocol (OR, 0.370; 95% CI, 0.160-0.854; p = 0.006) and supramesocolic surgery (OR, 0.371; 95% CI, 0.158-0.871; p = 0.023).
The study identified several factors associated with an encouraging 1-year mortality rate in this setting. These results highlight the need for identification of suitable targets to optimize pre-, intra-, and postoperative management in order to improve outcomes for this vulnerable population.
接受大腹部手术的老年患者数量正在增加,但影响其术后结局的因素仍不清楚。本研究旨在确定与接受大腹部手术的老年(≥80 岁)癌症患者的 1 年死亡率相关的因素。
本回顾性队列研究于 2009 年 3 月至 2020 年 12 月进行。共纳入 378 名年龄≥80 岁接受大腹部手术的患者。主要结局为 1 年死亡率,并分析与死亡率相关的因素。
在 378 名患者中,92 名在 1 年内死亡(24.3%),而 30 天死亡率为 4%(n=15)。多因素分析中,与 1 年死亡率独立相关的因素包括术前东部合作肿瘤学组(ECOG)表现状态(PS)评分大于 1(比值比[OR],3.189;95%置信区间[CI],1.595-6.377;p=0.001)、术前体重减轻大于 3kg(OR,2.145;95%CI,1.044-4.404;p=0.038)、术中使用血管加压药(OR,3.090;95%CI,1.188-8.042;p=0.021)和术后红细胞单位(OR,1.212;95%CI,1.045-1.405;p=0.011)。根据术后恢复加速(ERAS)方案(OR,0.370;95%CI,0.160-0.854;p=0.006)和超肠系膜手术(OR,0.371;95%CI,0.158-0.871;p=0.023)与围手术期管理相关的生存与围手术期管理相关。
本研究确定了与该人群中令人鼓舞的 1 年死亡率相关的几个因素。这些结果强调需要确定合适的目标,以优化术前、术中和术后管理,从而改善这一脆弱人群的结局。